J Picazo

Summary

Country: Spain

Publications

  1. ncbi In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain
    Carmen Betriu
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Spain
    Antimicrob Agents Chemother 46:892-5. 2002
  2. ncbi Management of the febrile neutropenic patient: a consensus conference
    Juan J Picazo
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain
    Clin Infect Dis 39:S1-6. 2004
  3. ncbi [Consensus document on vaccination against influenza in health care workers]
    J J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Spain
    Rev Esp Quimioter 25:226-39. 2012
  4. ncbi Management of the febrile neutropenic patient
    Juan J Picazo
    Department of Clinical Microbiology, Hospital Universitario de San Carlos, Universidad Complutense de Madrid, Spain
    Int J Antimicrob Agents 26:S120-2; discussion S133-40. 2005
  5. ncbi [Antimicrobial resistance surveillance: VIRA STUDY 2006]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 24:617-28. 2006
  6. ncbi [Surveillance of antimicrobial resistance: VIRA study 2004]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Spain
    Enferm Infecc Microbiol Clin 22:517-25. 2004
  7. ncbi Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines
    J J Picazo
    Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain
    Clin Microbiol Infect 15:4-6. 2009
  8. ncbi [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 28:13-6. 2010
  9. ncbi [Respiratory infections in adults hospitalized in internal medicine and pneumology departments. DIRA (Adult Respiratory Infection Day) study]
    Juan J Picazo
    Servicio de Microbiología Clínica Hospital Clínico San Carlos Madrid Spain
    Enferm Infecc Microbiol Clin 21:180-7. 2003
  10. ncbi Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid
    J Picazo
    Microbiology Department, Hospital Clinico San Carlos, c Martin Lagos s n, 28040 Madrid, Spain
    Vaccine 29:1770-6. 2011

Collaborators

Detail Information

Publications42

  1. ncbi In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain
    Carmen Betriu
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Spain
    Antimicrob Agents Chemother 46:892-5. 2002
    ....
  2. ncbi Management of the febrile neutropenic patient: a consensus conference
    Juan J Picazo
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain
    Clin Infect Dis 39:S1-6. 2004
  3. ncbi [Consensus document on vaccination against influenza in health care workers]
    J J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Spain
    Rev Esp Quimioter 25:226-39. 2012
    ..This recommendation is based on 3 pillars: argument of necessity, ethics and exemplary...
  4. ncbi Management of the febrile neutropenic patient
    Juan J Picazo
    Department of Clinical Microbiology, Hospital Universitario de San Carlos, Universidad Complutense de Madrid, Spain
    Int J Antimicrob Agents 26:S120-2; discussion S133-40. 2005
    ..Finally, the document should provide a detailed, stepwise management algorithm, addressing the initial empirical antimicrobial therapy and the antimicrobial therapy on days 3-5 and days 5-7 of therapy...
  5. ncbi [Antimicrobial resistance surveillance: VIRA STUDY 2006]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 24:617-28. 2006
    ....
  6. ncbi [Surveillance of antimicrobial resistance: VIRA study 2004]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Spain
    Enferm Infecc Microbiol Clin 22:517-25. 2004
    ..The objective of the study was to know the current situation of the antimicrobial sensitivity patterns of the main multi-resistant bacteria and to analyze any possible changes with respect to the VIRA study carried out in 2001...
  7. ncbi Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines
    J J Picazo
    Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain
    Clin Microbiol Infect 15:4-6. 2009
    ..Although the recent WHO position paper on childhood immunizations speaks to the growing resistance of pneumococci, antibiotic resistance in Spain is noted to be decreasing and must be evaluated in conjunction with global studies...
  8. ncbi [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Espana
    Enferm Infecc Microbiol Clin 28:13-6. 2010
    ....
  9. ncbi [Respiratory infections in adults hospitalized in internal medicine and pneumology departments. DIRA (Adult Respiratory Infection Day) study]
    Juan J Picazo
    Servicio de Microbiología Clínica Hospital Clínico San Carlos Madrid Spain
    Enferm Infecc Microbiol Clin 21:180-7. 2003
    ....
  10. ncbi Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007-2009) laboratory-based surveillance in Madrid
    J Picazo
    Microbiology Department, Hospital Clinico San Carlos, c Martin Lagos s n, 28040 Madrid, Spain
    Vaccine 29:1770-6. 2011
    ....
  11. ncbi Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar
    J Picazo
    Microbiology Department, Hospital Clinico San Carlos, c Martin Lagos s n, 28040 Madrid, Spain
    Clin Vaccine Immunol 18:89-94. 2011
    ..After PCV7 implementation, non-PCV7 serotypes caused 95.5% of IPDs. The new 13-valent conjugate vaccine would provide 79.1% coverage of serotypes responsible for IPDs in this series...
  12. ncbi Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers
    Juan J Picazo
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, 28040 Madrid, Spain
    Diagn Microbiol Infect Dis 64:448-51. 2009
    ..These data suggest that daptomycin could be useful for the treatment of bloodstream infections caused by staphylococci...
  13. ncbi Comparative in vitro activity of ceftobiprole against Gram-positive cocci
    Carmen Betriu
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, 28040 Madrid, Spain
    Int J Antimicrob Agents 36:111-3. 2010
    ..6% of all streptococci tested at <or=0.5 microg/mL. Based on these results, ceftobiprole appears to be a promising agent for the treatment of infections caused by multidrug-resistant Gram-positive pathogens...
  14. ncbi Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain
    Carmen Betriu
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Madrid, Spain
    Antimicrob Agents Chemother 54:2212-5. 2010
    ....
  15. ncbi [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]
    F Baquero
    , , Madrid, Spain
    Rev Esp Quimioter 19:51-9. 2006
    ..The carbapenems ertapenem, imipenem and meropenem and the aminoglycoside amikacin were highly active in vitro against Enterobacteriaceae isolated from intra-abdominal sites, including ESBL-producing organisms...
  16. ncbi Candidemia in the critically ill patient
    Juan J Picazo
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Madrid, Spain
    Int J Antimicrob Agents 32:S83-5. 2008
    ..The efficacy and safety profile of the candins make them the best option for treating invasive candidiasis in the critically ill patient...
  17. ncbi In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates
    Iciar Rodriguez-Avial
    Servicio de Microbiologia, Hospital Clinico San Carlos, Plaza de Cristo Rey s n, 28040 Madrid, Spain
    Int J Antimicrob Agents 27:303-6. 2006
    ..The high in vitro activity of tigecycline against tetracycline- and ciprofloxacin-resistant strains suggests a potential therapeutic role in the treatment of infections that involve Campylobacter spp...
  18. ncbi Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain
    Carmen Betriu
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Plaza Cristo Rey s n, 28040 Madrid, Spain
    Antimicrob Agents Chemother 52:2686-90. 2008
    ..Increasing resistance to clindamycin and moxifloxacin was observed. Susceptibility to imipenem, piperacillin-tazobactam, and metronidazole remained unchanged...
  19. ncbi Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study
    Carmen Betriu
    Department of Clinical Microbiology, , 28040 Madrid, Spain
    Diagn Microbiol Infect Dis 56:437-44. 2006
    ..The results of this study confirm the excellent activity of tigecycline against multiresistant Gram-positive and Gram-negative pathogens...
  20. ncbi Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus
    Gracia Morales
    Clinical Microbiology Service, Hospital Clinico San Carlos, Madrid, Spain
    Clin Infect Dis 50:821-5. 2010
    ..We investigated the mechanism of resistance--point mutations in domain V of 23S ribosomal RNA (rRNA) or presence of the cfr gene--involved in the outbreak...
  21. ncbi Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae
    Esther Culebras
    Servicio de Microbiologia, Hospital Clinico San Carlos, Plaza Cristo Rey s n, Madrid, 28040, Spain
    J Antimicrob Chemother 56:836-40. 2005
    ..To study the regulatory region of a constitutively expressed erm(A) gene in Streptococcus agalactiae clinical isolates...
  22. ncbi Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence
    Fatima Lopez
    Department of Microbiology, Hospital Clinico San Carlos, Plaza de Cristo Rey s n 28040, Madrid, Spain
    Diagn Microbiol Infect Dis 66:73-7. 2010
    ..faecium isolate. A total of 131 Q/D-nonsusceptible enterococci only contained the erm(B) gene. The erm(B) promoter sequence reveals no differences between the strains analyzed, regardless of the Q/D MIC value...
  23. ncbi Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition
    Carmen Gonzalez
    Department of Clinical Microbiology, Hospital Universitario San Carlos, Madrid, Spain
    Int J Infect Dis 7:102-8. 2003
    ..The aim of the study was to ascertain the clinical and epidemiologic characteristics of patients with nosocomial or community-acquired Staphylococcus aureus bacteremic pneumonia...
  24. ncbi Distribution of tetracycline resistance genes tet(M), tet(O), tet(L) and tet(K) in blood isolates of viridans group streptococci harbouring erm(B) and mef(A) genes. Susceptibility to quinupristin/dalfopristin and linezolid
    Iciar Rodriguez-Avial
    Department of Clinical Microbiology, Hospital Cli;nico San Carlos, , 28040, Madrid, Spain
    Int J Antimicrob Agents 21:536-41. 2003
    ..We found three isolates resistant to quinupristin/dalfopristin, all of them were erythromycin and tetracycline-resistant. For all isolates tested, linezolid MICs were <or=2 mg/l...
  25. ncbi Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae
    Esther Culebras
    Department of Clinical Microbiology, Hospital Universitario San Carlos, 28040 Madrid, Spain
    Antimicrob Agents Chemother 46:1574-6. 2002
    ..The tet(M) and tet(O) genes were responsible for tetracycline resistance. Random amplification of polymorphic DNA indicated different clonal origins of the isolates...
  26. ncbi In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species
    Iciar Rodriguez-Avial
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, Plaza de Cristo Rey s n, 28040 Madrid, Spain
    Antimicrob Agents Chemother 49:820-3. 2005
    ..Heterogeneity in the susceptibility patterns and macrolide resistance phenotypes and genotypes in the different groups of VGS was detected. We found seven telithromycin-resistant S. bovis isolates all harboring the erm(B) gene...
  27. ncbi Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones
    Iciar Rodriguez-Avial
    Servicio de Microbiologia, Hospital Clinico San Carlos, 28040 Madrid, Spain
    Diagn Microbiol Infect Dis 52:261-4. 2005
    ....
  28. ncbi Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002)
    Carmen Betriu
    Department of Clinical Microbiology, Hospital Clinico San Carlos, 28040 Madrid, Spain
    Diagn Microbiol Infect Dis 53:221-3. 2005
    ..fragilis group organisms to trovafloxacin and moxifloxacin and emphasizes the need to perform periodic antimicrobial susceptibility tests to guide the selection of appropriate antimicrobial therapy...
  29. ncbi Comparative in vitro activity and the inoculum effect of ertapenem against Enterobacteriaceae resistant to extended-spectrum cephalosporins
    Carmen Betriu
    Department of Clinical Microbiology, Hospital Clinico San Carlos, Plaza Cristo Rey s n, 28040 Madrid, Spain
    Int J Antimicrob Agents 28:1-5. 2006
    ..The data from this study suggest that this new carbapenem may be useful for treating mixed infections involving Enterobacteriaceae isolates resistant to third-generation cephalosporins...
  30. ncbi [The role of the rotavirus vaccine in childhood vaccination schedules]
    F Gimenez Sanchez
    Comité Asesor de Vacunas de la Asociación Española de Pediatría, Madrid, Spain
    An Pediatr (Barc) 64:573-7. 2006
    ..When these vaccines become available in Europe, a reduction in hospitalizations, medical consultations, and days of work lost can be expected...
  31. ncbi Diversity of the G3 genes of human rotaviruses in isolates from Spain from 2004 to 2006: cross-species transmission and inter-genotype recombination generates alleles
    Jorge Martinez-Laso
    Unidad de Inmunoterapia Celular, Centro Nacional de Microbiologia Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain
    J Gen Virol 90:935-43. 2009
    ..These findings strongly suggest multiple inter-species transmission events between different non-human mammalian species and humans...
  32. ncbi [Cellulitis after a cat bite]
    J Perez Garcia
    Servicio de Microbiologia Clinica, Hospital Clinico San Carlos, C Profesor Martin Lagos s n, 28040 Madrid, Spain
    Rev Esp Quimioter 22:221-3. 2009
    ..We present two cases of Pasteurella multocida infection after a cat bite.Thus, in this article we review the most relevant clinical features related with this aetiological agent and some aspects about antimicrobial susceptibility...
  33. ncbi Phylogeny of G9 rotavirus genotype: a possible explanation of its origin and evolution
    Jorge Martinez-Laso
    Unidad de Inmunoterapia Celular, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Ctra Majadahonda Pozuelo, Km 2 2, 28220 Majadahonda, Madrid, Spain
    J Clin Virol 44:52-7. 2009
    ..G9 rotavirus genotype was isolated in the 1980s and re-emerged without a clear explanation in the mid-1990s as one of the most frequently occurring genotypes with distinct genetic and molecular characteristics...
  34. ncbi Significance of nested PCR and quantitative real time PCR for cytomegalovirus detection in renal transplant recipients
    Atef Kanaan
    Department of Microbiology, , , 28040 Madrid, Spain
    Int J Antimicrob Agents 24:455-62. 2004
    ..Sixty-seven blood donors were used as controls. The results show that the quantitative real-time PCR assay could be of great interest for predicting CMV disease, and to monitor the onset of pre-emptive therapy...
  35. ncbi [Surveillance for antimicrobial resistance: VIRA Study]
    Juan J Picazo

    Enferm Infecc Microbiol Clin 20:503-10. 2002
    ....
  36. ncbi [Respiratory infections outside the hospital. DIRA study]
    Juan J Picazo

    Enferm Infecc Microbiol Clin 21:410-6. 2003
    ..DISCUSSION: Infection in general and respiratory infection in particular is frequently attended in primary care. Antibiotics are widely used in our setting and self-medication is common...
  37. ncbi [Epidemiologic study of infection by resistant gram-positive bacteria (G + R Study)]
    Carmen Betriu
    Servicio de Microbiología Clínica Hospital Clínico San Carlos Madrid España
    Enferm Infecc Microbiol Clin 21:7-11. 2003
    ..The study was performed between December 2000 and March 2001, using two one-week time periods...
  38. ncbi [Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement]
    Marc Miravitlles

    Arch Bronconeumol 44:100-8. 2008
  39. ncbi Fluoroquinolone resistance among invasive viridans group streptococci and Streptococcus bovis isolated in Spain
    Iciar Rodriguez-Avial
    Int J Antimicrob Agents 29:478-80. 2007
  40. ncbi Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever
    Huang Xiao Jun
    Int J Antimicrob Agents 26:S128-32; discussion S133-40. 2005
  41. ncbi Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia
    Carmen Betriu
    J Antimicrob Chemother 50:758-9. 2002
  42. ncbi Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Carmen Betriu
    J Antimicrob Chemother 50:436-8. 2002